JOHNSON & JOHNSON is 276.0x more valuable than HUTCHMED (China) Ltd by market capitalization ($573.98 B vs $2.08 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | HCM | JNJ |
|---|---|---|
| Market cap | $2.08 B | $573.98 B |
| US-listed rank | #2073 | #20 |
| Revenue (latest FY) | $548.51M | $94.19B |
| Net income (latest FY) | $456.91M | $26.80B |
| Net margin | 83.3% | 28.5% |
| P/E (trailing FY) | 4.6 | 21.4 |
| SEC filings | 589 | 984 |
JOHNSON & JOHNSON is 276.0x more valuable than HUTCHMED (China) Ltd by market capitalization ($573.98 B vs $2.08 B).
In their latest fiscal years, HUTCHMED (China) Ltd reported $548.51M in revenue while JOHNSON & JOHNSON reported $94.19B.
Full pages: HUTCHMED (China) Ltd and JOHNSON & JOHNSON, or browse the full rankings.